Back to search

Article

Giving Drugs A Second Chance: Antibacterial and Antibiofilm Effects of Ciclopirox and Ribavirin Against Cystic Fibrosis <em>Pseudomonas Aeruginosa</em> Strains

2022-04-22

Abstract excerpt

Drug repurposing is an attractive strategy for developing new antibacterial molecules. Herein, we evaluated the in vitro antibacterial, antibiofilm, and antivirulence activities of eight FDA-approved &ldquo;non-antibiotic&rdquo; drugs, comparatively to tobramycin, against selected Pseudomonas aeruginosa strains from cystic fibrosis patients. MIC and MBC values were measured by broth microdilution methods. Time-kil...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4f3f62d9-4a49-57f6-9eb3-555d475172cf
DOI
10.20944/preprints202204.0212.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Giving Drugs A Second Chance: Antibacterial and Antibiofilm Effects of Ciclopirox and Ribavirin Against Cystic Fibrosis <em>Pseudomonas Aeruginosa</em> StrainsDOI 10.20944/preprints202204.0212.v1
Repurposing High-Throughput Screening Identifies Unconventional Drugs with Antibacterial and Antibiofilm Activities against Pseudomonas aeruginosa under Experimental Conditions Relevant to Cystic FibrosisSemantic proximity
Beyond antibiotics: Emerging antivirulence strategies to combat Pseudomonas aeruginosa in cystic fibrosisSemantic proximity
Repurposing of nucleoside- and nucleobase-derivative drugs as antibiotics and biofilm inhibitorsSemantic proximity
Toward repurposing ciclopirox as an antibiotic against drug-resistant Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae.Semantic proximity
Multilevel computational approach to unlock the potential inhibitors of biofilm-EPS, persistence and quinolone signalling in <i>Pseudomonas aeruginosa</i> using mangrove-derived bioactive phytochemicalsSemantic proximity
Pharmacological strategies for targeting biofilms in otorhinolaryngologic infections and overcoming antimicrobial resistance (Review)Semantic proximity
Disrupting Antimicrobial Resistance: Unveiling the Potential of Vitamin C in Combating Biofilm Formation in Drug-Resistant BacteriaSemantic proximity
Propionate restores susceptibility to colistin-resistant clinical isolates of Pseudomonas aeruginosa.Semantic proximity
Evaluation of antibiofilm activity of cefiderocol alone and in combination with imipenem against Pseudomonas aeruginosaSemantic proximity
Antimicrobial Activity of Ceftazidime-Avibactam, Ceftolozane-Tazobactam, Cefiderocol, and Novel Darobactin Analogs against Multidrug-Resistant Pseudomonas aeruginosa Isolates from Pediatric and Adolescent Cystic Fibrosis PatientsSemantic proximity
In vitro activity of cefiderocol against Pseudomonas aeruginosa isolated from adult patients with cystic fibrosisSemantic proximity
Targeting Ocular Biofilms with Plant-Derived Antimicrobials in the Era of Antibiotic ResistanceSemantic proximity
Select a neighboring publication to make it the new centre.